Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS

Holly Coltart; Kate El Bouzidi; Larissa Mulka; Steve Connor; Julie Chandra; Elizabeth Hamlyn

doi:10.1097/QAD.0000000000003395

Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS

Holly Coltart^*
, Kate El Bouzidi
, Larissa Mulka
, Steve Connor
, Julie Chandra
, Elizabeth Hamlyn

^*Corresponding author for this work

Imaging and Biomedical Engineering

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	199-200
Number of pages	2
Journal	AIDS
Volume	37
Issue number	1
DOIs	https://doi.org/10.1097/QAD.0000000000003395
Publication status	Published - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/QAD.0000000000003395

Cite this

@article{45806d9a35ff411e86cd64233162e0db,

title = "Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS",

author = "Holly Coltart and \{El Bouzidi\}, Kate and Larissa Mulka and Steve Connor and Julie Chandra and Elizabeth Hamlyn",

year = "2023",

month = jan,

day = "1",

doi = "10.1097/QAD.0000000000003395",

language = "English",

volume = "37",

pages = "199--200",

journal = "AIDS",

issn = "0269-9370",

publisher = "LIPPINCOTT WILLIAMS \& WILKINS",

number = "1",

}

TY - JOUR

T1 - Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS

AU - Coltart, Holly

AU - El Bouzidi, Kate

AU - Mulka, Larissa

AU - Connor, Steve

AU - Chandra, Julie

AU - Hamlyn, Elizabeth

PY - 2023/1/1

Y1 - 2023/1/1

UR - https://www.scopus.com/pages/publications/85143563341

U2 - 10.1097/QAD.0000000000003395

DO - 10.1097/QAD.0000000000003395

M3 - Letter

C2 - 36476458

AN - SCOPUS:85143563341

SN - 0269-9370

VL - 37

SP - 199

EP - 200

JO - AIDS

JF - AIDS

IS - 1

ER -

Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS

UN SDGs

Access to Document

Other files and links

Cite this